Ventana unveils new cancer-testing method

2012-09-07T13:29:00Z 2012-09-07T14:27:53Z Ventana unveils new cancer-testing methodDavid Wichner Arizona Daily Star Arizona Daily Star
September 07, 2012 1:29 pm  • 

Oro Valley-based Ventana Medical Systems said it is introducing a first-of-its-kind, fully-automated sample staining technique that will allow researchers to examine two key indicators related to cancer in the same section of tumor tissue.

Ventana said studying miRNA — micro ribonucleic acid — and proteins together in tumors allows researchers to study how their relationship plays a role in driving tumor cell growth in many cancer types including breast, lung, prostate and colorectal cancers.

The application, which is designed for use with Ventana’s Discovery Ultra automated slide-staining instrument, also uses non-enzyme pretreatments to better preserve tissue structure, said Ventana, part of Swiss drug giant Roche.

Check out the entire news release, with photos and videos, at

Copyright 2015 Arizona Daily Star. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.